Poland· PL-100462559
Sitagliptin + Metformin Medreg
A metformin and sitagliptin product containing sitagliptinum + metformini hydrochloridum, registered in Poland by Medreg s.r.o.. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Metformin and sitagliptin is registered in 14 of 19 countries.
Countries holding a registration under ATC A10BD07 (metformin and sitagliptin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Metformin and sitagliptin · ATC A10BD07
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Sitagliptinum + Metformini hydrochloridum
- Manufacturer
- Medreg s.r.o.
- Country
- Poland (PL)
- ATC code
- A10BD07
- ATC class
- Metformin and sitagliptin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 11
- gtin08595566458836
- gtin08595566458843
- gtin08595566458850
- gtin08595566458867
- gtin08595566458874
- gtin08595566458881
- gtin08595566458898
- gtin08595566458904
- gtin08595566458911
- gtin08595566458812
- gtin08595566458829
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for metformin and sitagliptin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metformin and sitagliptin · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Metformin and sitagliptin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaANSIFORA DUOVipharm S.A., Ożarów Mazowiecki
- United StatesJANUMETMerck Sharp & Dohme LLC
- SpainDISIMET 50 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLaboratorios Alter S.A.
- SwitzerlandJanumet
- NetherlandsEfficib 50 mg/1000 mg, filmomhulde tablettenMerck Sharp & Dohme B.V.
- SwedenEfficib 50 mg/1000 mg Filmdragerad tablettMerck Sharp & Dohme BV
- FinlandBrandasitGenepharm S.A.
- ItalyADIABINPHARMEXTRACTA S.P.A.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Jamesi, Jansitin Duo
- Belgium · Sitagliptin/Metformin Grindeks, Sitagliptin/Metformin Sandoz
- Bulgaria · Jansitin Duo, Metlinka 50 Mg/1000 Mg
- Cyprus · Diabremet, Jivolar
- Czechia · Ansifora Duo, Asigefort
- Germany · Metformax Combi, Metsunix
- Denmark · Glerova, Sitagliptin/Metformin "sandoz"
- Estonia · Asigefort, Diabremet
- Spain · Disimet, Estequen
- Finland · Brandasit, Sitagliptin/Metformin Glenmark
- France · Sitagliptine/Chlorhydrate De Metformine Micro Labs, Sitagliptine/Chlorhydrate De Metformine Olpha
- United Kingdom (Northern Ireland) · Sitagliptin / Metformin Hydrochloride Macleods, Sitagliptin / Metformin Hydrochloride Macleods Pharma Uk
- Greece · Brandasit, Co-Fineria
- Croatia · Condias Combi, Eprocliv
- Hungary · Ansifora Duo, Asigefort
- Ireland · Sitagliptin And Metformin Hydrochloride Ascend, Sitagliptin/Metformin Clonmel
- Iceland · Aps, Efficib
- Italy · Adiabin, Diesmit
- Liechtenstein · Efficib, Janumet
- Lithuania · Asigefort, Eprocliv
- Latvia · Asigefort, Eprocliv
- Malta · Combodiab Galenicum Health, Diabremet
- Netherlands · Eprocliv, Fordiab
- Norway · Efficib, Janumet
- Portugal · Jivolar, Metformina + Sitagliptina Alter
- Romania · Eprocliv, Jamesi
- Sweden · Jivolar, Mifomet
- Slovenia · Eprocliv, Jivolar
- Slovakia · Ansifora Duo, Asigefort
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a35e57ab-84dc-4bdb-b886-dbf5c64f7cf2 GET /v1/drugs/a35e57ab-84dc-4bdb-b886-dbf5c64f7cf2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "50 mg + 1000 mg",
"packaging": "08595566458812 ¦ Rp ¦ 161563\n20 tabl.\n08595566458829 ¦ Rp ¦ 161564\n28 tabl.\n08595566458836 ¦ Rp ¦ 161565\n30 tabl. w blistrze\n08595566458843 ¦ Rp ¦ 161566\n56 tabl.\n08595566458850 ¦ Rp ¦ 161567\n60 tabl. w blistrze\n08595566458867 ¦ Rp ¦ 161568\n98 tabl.\n08595566458874 ¦ Rp ¦ 161569\n100 tabl.\n08595566458881 ¦ Rp ¦ 161570\n196 tabl.\n08595566458898 ¦ Rp ¦ 161571\n200 tabl.\n08595566458904 ¦ Rp ¦ 161572\n30 tabl. w pojemniku\n08595566458911 ¦ Rp ¦ 161573\n60 tabl. w pojemniku",
"substance": "Sitagliptinum 50 mg + Metformini hydrochloridum 1000 mg",
"common_name": "Sitagliptinum + Metformini hydrochloridum",
"pl_product_id": "100462559",
"pozwolenie_nr": "29012",
"auth_procedure": "DCP",
"authorisation_validity": "2030-04-18"
}See everything about metformin and sitagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.